Enhanced absorption of indomethacin after oral or rectal administration of a self-emulsifying system containing indomethacin to rats

被引:89
作者
Kim, JY [1 ]
Ku, YS [1 ]
机构
[1] Ewha Womans Univ, Dept Pharmaceut, Coll Pharm, Sodaemun Ku, Seoul 120750, South Korea
关键词
indomethacin; SES (Tween 85 : ethyl oleate; 3; 7); gelatin hollow type rectal suppository; rats;
D O I
10.1016/S0378-5173(99)00367-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A self-emulsifying system (SES), a mixture of an oil and a surfactant which forms an oil-in-water emulsion, is expected to improve the in vitro drug dissolution and enhance the in vivo drug absorption. In this study, a poorly water-soluble drug, indomethacin (IDM) was incorporated into the SES to increase bioavailability. The SES with 30% of Tween 85 and 70%: of ethyl oleate, EO (w/w) was selected as an optimized formulation (high drug loading, low surfactant concentration. and small particle size). After an oral administration of the SES containing IDM and IDM suspension, (IDM was suspended in methyl cellulose), 22.5 mg/kg as IDM, to rats, the area under the plasma concentration-time curve from time zero to the last measured time in plasma, 12 h (AUC(0 12 h)) was significantly greater (57% increase) in the SES, suggesting that oral absorption of IDM increased significantly by the SES. After a rectal administration of gelatin hollow type suppositories, filled with the SES containing IDM and IDM powder physically mixed with the SES, 22.5 mg/kg, to rats, the AUG(0 12 h) also increased significantly (41% increase) by the SES, suggesting that rectal absorption of IDM also increased significantly by the SES. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:81 / 89
页数:9
相关论文
共 11 条
[1]   SELF-EMULSIFYING DRUG DELIVERY SYSTEMS - FORMULATION AND BIOPHARMACEUTIC EVALUATION OF AN INVESTIGATIONAL LIPOPHILIC COMPOUND [J].
CHARMAN, SA ;
CHARMAN, WN ;
ROGGE, MC ;
WILSON, TD ;
DUTKO, FJ ;
POUTON, CW .
PHARMACEUTICAL RESEARCH, 1992, 9 (01) :87-93
[2]   CRITICAL EVALUATION OF THE POTENTIAL ERROR IN PHARMACOKINETIC STUDIES OF USING THE LINEAR TRAPEZOIDAL RULE METHOD FOR THE CALCULATION OF THE AREA UNDER THE PLASMA LEVEL TIME CURVE [J].
CHIOU, WL .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1978, 6 (06) :539-546
[3]   MICELLAR SOLUBILIZATION OF CLOFAZIMINE ANALOGS IN AQUEOUS-SOLUTIONS OF IONIC AND NONIONIC SURFACTANTS [J].
FAHELELBOM, KMS ;
TIMONEY, RF ;
CORRIGAN, OI .
PHARMACEUTICAL RESEARCH, 1993, 10 (04) :631-634
[4]   PHARMACOKINETICS AND PHARMACODYNAMICS OF FUROSEMIDE IN PROTEIN-CALORIE MALNUTRITION [J].
KIM, SH ;
CHOI, YM ;
LEE, MG .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1993, 21 (01) :1-17
[5]   Pharmacokinetics of a new carbapenem, DA-1131, after intravenous administration to rats with uranyl nitrate-induced acute renal failure [J].
Kim, SH ;
Shim, HJ ;
Kim, WB ;
Lee, MG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (05) :1217-1221
[6]  
Kim YG, 1996, BIOPHARM DRUG DISPOS, V17, P183
[7]  
MYLES AMC, 1990, J PHARM PHARMACOL, V42, P7
[8]  
OHNISHI N, 1986, CHEM PHARM BULL, V34, P2996
[9]   PARTICLE DESIGN OF TOLBUTAMIDE BY THE SPHERICAL CRYSTALLIZATION TECHNIQUE .3. MICROMERITIC PROPERTIES AND DISSOLUTION RATE OF TOLBUTAMIDE SPHERICAL AGGLOMERATES PREPARED BY THE QUASI-EMULSION SOLVENT DIFFUSION METHOD AND THE SOLVENT CHANGE METHOD [J].
SANO, A ;
KURIKI, T ;
KAWASHIMA, Y ;
TAKEUCHI, H ;
HINO, T ;
NIWA, T .
CHEMICAL & PHARMACEUTICAL BULLETIN, 1990, 38 (03) :733-739
[10]  
SEKIKAWA H, 1983, CHEM PHARM BULL, V31, P1350